ICyte Platform December 1, 2022 Entering the New Era of Data-Driven Drug Commercialization 5 Minute Read Co-Founder and Chief Operating Officer Josh Halpern reviews key industry trends impacting product commercialization and access, including the shift to true data-driven commercialization, highlighted at the Access Insights Conference...
Contracts & Pricing November 23, 2022 Consumer Price Index, Pricing Transparency Updates, and the Impact of Digital... 5 Minute Read Regulatory and legal updates on three significant regulatory topics, including consumer price index, pricing transparency updates, and the impact of digital pharmacies.
Contracts & Pricing October 27, 2022 Stacking Discounts for Best Price, PHS & 340B, HHS Ruling 3 Minute Read Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.
Contracts & Pricing September 27, 2022 FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice 4 Minute Read Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.
Contracts & Pricing August 29, 2022 The Impact of the Inflation Reduction Act on the Pharmaceutical Industry 4 Minute Read Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.
Contracts & Pricing August 19, 2022 NDC Format Proposal, Focus on PBMs, False Claims Act 4 Minute Read August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.
Contracts & Pricing July 19, 2022 Legal Review: Medicare Program, 340B, and State Price Updates 6 Minute Read July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.
Channel July 13, 2022 Top Trends in Specialty Network and Service Design 5 Minute Read Benchmarks on specialty networks using our exclusive ICyte channel and patient access data: what specialty networks look like, who's included, and how network sizes vary by therapeutic category.
Contracts & Pricing June 27, 2022 Pharma vs. 340B 4 Minute Read This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
